KURT VON EMSTER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KURT VON EMSTER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KURT VON EMSTER. KURT VON EMSTER is Director in CymaBay Therapeutics, Inc. ($CBAY) and Director in Vaxcyte, Inc. ($PCVX) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Vera Therapeutics, Inc. ($VERA).
Latest Insider Trading Transactions of KURT VON EMSTER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRSP, CBAY, PCVX, VERA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2021 | VERA | Vera Therapeutics, ... | EMSTER KURT VON | Director | Option Exercise | A | 11.00 | 9,925 | 109,175 | 9,925 | |
Feb 01 2021 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 5.78 | 32,000 | 184,960 | 32,000 | |
Jun 23 2020 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Option Exercise | C | 0.00 | 298,917 | 0 | 0 | |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Option Exercise | C | 0.00 | 454,812 | 0 | 0 | |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Option Exercise | C | 0.00 | 1,217,074 | 0 | 0 | |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Option Exercise | C | 0.00 | 2,185,415 | 0 | 0 | |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Buy | P | 16.00 | 12,500 | 200,000 | 4,168,718 | 4.2 M to 4.2 M (+0.30 %) |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Buy | C | 0.00 | 298,917 | 0 | 4,156,218 | 3.9 M to 4.2 M (+7.75 %) |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Buy | C | 0.00 | 454,812 | 0 | 3,857,301 | 3.4 M to 3.9 M (+13.37 %) |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Buy | C | 0.00 | 1,217,074 | 0 | 3,402,489 | 2.2 M to 3.4 M (+55.69 %) |
Jun 18 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Buy | C | 0.00 | 2,185,415 | 0 | 2,185,415 | 0 to 2.2 M |
Jun 15 2020 | PCVX | Vaxcyte, Inc. | EMSTER KURT VON | Director | Option Exercise | A | 16.00 | 40,000 | 640,000 | 40,000 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Dec 19 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 29.70 | 69,925 | 2,077,101 | 1,164,268 | 1.2 M to 1.2 M (-5.67 %) |
Dec 19 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 33.17 | 3,009 | 99,797 | 1,234,193 | 1.2 M to 1.2 M (-0.24 %) |
Dec 19 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 7.43 | 53,492 | 397,365 | 131,036 | 184.5 K to 131 K (-28.99 %) |
Dec 19 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 8.17 | 88,889 | 726,223 | 184,528 | 273.4 K to 184.5 K (-32.51 %) |
Jun 18 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
Jun 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | X | 5.75 | 2,000 | 11,500 | 0 | |
Jun 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.51 | 920 | 11,509 | 18,316 | 19.2 K to 18.3 K (-4.78 %) |
Jun 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | X | 5.75 | 2,000 | 11,500 | 19,236 | 21.2 K to 19.2 K (-9.42 %) |
Jun 07 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | X | 5.75 | 2,000 | 11,500 | 0 | |
Jun 07 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 12.51 | 920 | 11,509 | 18,316 | 19.2 K to 18.3 K (-4.78 %) |
Jun 07 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | X | 5.75 | 2,000 | 11,500 | 19,236 | 21.2 K to 19.2 K (-9.42 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 52.20 | 8,900 | 464,540 | 1,237,202 | 1.2 M to 1.2 M (-0.71 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 52.93 | 20,881 | 1,105,313 | 1,246,102 | 1.3 M to 1.2 M (-1.65 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 53.86 | 53,927 | 2,904,578 | 1,266,983 | 1.3 M to 1.3 M (-4.08 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 54.99 | 126,901 | 6,978,273 | 1,320,910 | 1.4 M to 1.3 M (-8.77 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 55.72 | 73,144 | 4,075,723 | 1,447,811 | 1.5 M to 1.4 M (-4.81 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 56.90 | 116,247 | 6,614,129 | 1,520,955 | 1.6 M to 1.5 M (-7.10 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 51.73 | 8,633 | 446,554 | 1,637,202 | 1.6 M to 1.6 M (-0.52 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 52.46 | 127,890 | 6,708,611 | 1,645,835 | 1.8 M to 1.6 M (-7.21 %) |
May 15 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 53.36 | 113,477 | 6,054,736 | 1,773,725 | 1.9 M to 1.8 M (-6.01 %) |
Mar 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 15.51 | 13,353 | 207,105 | 273,417 | 286.8 K to 273.4 K (-4.66 %) |
Feb 20 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 14.49 | 68,712 | 995,637 | 286,770 | 355.5 K to 286.8 K (-19.33 %) |
Feb 15 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 16.69 | 162,979 | 2,720,120 | 355,482 | 518.5 K to 355.5 K (-31.44 %) |
Feb 15 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 13.51 | 55,078 | 744,104 | 518,461 | 573.5 K to 518.5 K (-9.60 %) |
Feb 12 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Buy | P | 6.50 | 153,846 | 999,999 | 1,753,846 | 1.6 M to 1.8 M (+9.62 %) |
Feb 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.14 | 18,831 | 228,608 | 460,456 | 479.3 K to 460.5 K (-3.93 %) |
Feb 01 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.23 | 12,300 | 150,429 | 569,385 | 581.7 K to 569.4 K (-2.11 %) |
Feb 01 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.22 | 85,339 | 1,042,843 | 581,685 | 667 K to 581.7 K (-12.79 %) |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.18 | 39,438 | 480,355 | 667,024 | 706.5 K to 667 K (-5.58 %) |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.18 | 39,438 | 480,355 | 667,024 | 706.5 K to 667 K (-5.58 %) |
Jan 24 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.40 | 138,253 | 1,437,831 | 706,462 | 844.7 K to 706.5 K (-16.37 %) |
Jan 22 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.25 | 130,584 | 1,338,486 | 844,715 | 975.3 K to 844.7 K (-13.39 %) |
Jan 22 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.21 | 13,632 | 139,183 | 975,299 | 988.9 K to 975.3 K (-1.38 %) |
Jan 11 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Buy | P | 22.75 | 65,934 | 1,499,999 | 1,887,202 | 1.8 M to 1.9 M (+3.62 %) |
Jan 09 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 26.96 | 92,337 | 2,489,406 | 1,821,268 | 1.9 M to 1.8 M (-4.83 %) |
Jan 09 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.21 | 4,300 | 43,903 | 988,931 | 993.2 K to 988.9 K (-0.43 %) |
Jan 04 2018 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 26.76 | 37,754 | 1,010,123 | 1,913,605 | 2 M to 1.9 M (-1.93 %) |
Dec 27 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.41 | 173,192 | 1,629,304 | 993,231 | 1.2 M to 993.2 K (-14.85 %) |
Nov 14 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.26 | 50,048 | 463,379 | 1,166,423 | 1.2 M to 1.2 M (-4.11 %) |
Nov 03 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.25 | 4,320 | 39,979 | 1,216,471 | 1.2 M to 1.2 M (-0.35 %) |
Nov 01 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.27 | 52,573 | 487,352 | 1,220,791 | 1.3 M to 1.2 M (-4.13 %) |
Nov 01 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.26 | 6,636 | 61,449 | 1,273,364 | 1.3 M to 1.3 M (-0.52 %) |
Oct 04 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 7.81 | 70,940 | 554,041 | 1,280,000 | 1.4 M to 1.3 M (-5.25 %) |
Oct 04 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 7.93 | 37,936 | 300,832 | 1,350,940 | 1.4 M to 1.4 M (-2.73 %) |
Oct 02 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 8.04 | 120,735 | 970,709 | 1,388,876 | 1.5 M to 1.4 M (-8.00 %) |
Oct 02 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 8.15 | 90,389 | 736,670 | 1,509,611 | 1.6 M to 1.5 M (-5.65 %) |
Aug 30 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 19.79 | 88,011 | 1,741,738 | 1,951,359 | 2 M to 2 M (-4.32 %) |
Aug 28 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 19.52 | 14,913 | 291,102 | 2,039,370 | 2.1 M to 2 M (-0.73 %) |
Aug 28 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 19.23 | 7,868 | 151,302 | 2,054,283 | 2.1 M to 2.1 M (-0.38 %) |
Aug 24 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.53 | 7,035 | 130,359 | 2,062,151 | 2.1 M to 2.1 M (-0.34 %) |
Aug 24 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.53 | 10,954 | 202,978 | 2,069,186 | 2.1 M to 2.1 M (-0.53 %) |
Aug 22 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.51 | 1,250 | 23,138 | 2,080,140 | 2.1 M to 2.1 M (-0.06 %) |
Aug 22 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.53 | 1,900 | 35,207 | 2,081,390 | 2.1 M to 2.1 M (-0.09 %) |
Aug 18 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.74 | 13,593 | 254,733 | 2,083,290 | 2.1 M to 2.1 M (-0.65 %) |
Aug 18 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 19.27 | 20,548 | 395,960 | 2,096,883 | 2.1 M to 2.1 M (-0.97 %) |
Aug 16 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 19.53 | 25,586 | 499,695 | 2,117,431 | 2.1 M to 2.1 M (-1.19 %) |
Aug 16 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 19.64 | 29,983 | 588,866 | 2,143,017 | 2.2 M to 2.1 M (-1.38 %) |
Aug 09 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.71 | 19,850 | 371,394 | 2,190,872 | 2.2 M to 2.2 M (-0.90 %) |
Aug 09 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.53 | 15,623 | 289,494 | 2,210,722 | 2.2 M to 2.2 M (-0.70 %) |
Aug 07 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 18.50 | 3,068 | 56,758 | 2,226,345 | 2.2 M to 2.2 M (-0.14 %) |
Aug 07 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.77 | 47,409 | 842,458 | 2,229,413 | 2.3 M to 2.2 M (-2.08 %) |
Aug 02 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.50 | 264 | 4,620 | 2,276,822 | 2.3 M to 2.3 M (-0.01 %) |
Aug 02 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.51 | 5,248 | 91,871 | 2,277,086 | 2.3 M to 2.3 M (-0.23 %) |
Jul 31 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.65 | 400 | 7,060 | 2,282,334 | 2.3 M to 2.3 M (-0.02 %) |
Jul 31 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.63 | 40,912 | 721,074 | 2,282,734 | 2.3 M to 2.3 M (-1.76 %) |
Jul 27 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.63 | 23,744 | 418,607 | 2,323,646 | 2.3 M to 2.3 M (-1.01 %) |
Jul 27 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.52 | 9,186 | 160,939 | 2,347,390 | 2.4 M to 2.3 M (-0.39 %) |
Jul 17 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.82 | 36,230 | 609,389 | 2,356,576 | 2.4 M to 2.4 M (-1.51 %) |
Jul 17 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.87 | 33,629 | 567,321 | 2,392,806 | 2.4 M to 2.4 M (-1.39 %) |
Jul 13 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.60 | 17,872 | 296,675 | 2,408,563 | 2.4 M to 2.4 M (-0.74 %) |
Jul 13 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.52 | 14,120 | 233,262 | 2,426,435 | 2.4 M to 2.4 M (-0.58 %) |
Jul 07 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.26 | 4,254 | 69,170 | 2,440,555 | 2.4 M to 2.4 M (-0.17 %) |
Jun 30 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.52 | 11,610 | 191,797 | 2,444,809 | 2.5 M to 2.4 M (-0.47 %) |
Jun 30 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.04 | 31,592 | 538,328 | 2,456,419 | 2.5 M to 2.5 M (-1.27 %) |
Jun 28 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 17.43 | 33,434 | 582,755 | 2,488,011 | 2.5 M to 2.5 M (-1.33 %) |
Jun 28 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.83 | 48,001 | 807,857 | 2,521,445 | 2.6 M to 2.5 M (-1.87 %) |
Jun 26 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.23 | 30,841 | 500,549 | 2,569,446 | 2.6 M to 2.6 M (-1.19 %) |
Jun 26 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Sell | S | 16.21 | 1,527 | 24,753 | 2,600,287 | 2.6 M to 2.6 M (-0.06 %) |
Jun 02 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | A | 13.62 | 15,000 | 204,300 | 15,000 | |
Feb 10 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | C | 0.00 | 191,764 | 0 | 0 | |
Feb 10 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | C | 0.00 | 2,354,050 | 0 | 0 | |
Feb 10 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Buy | P | 14.00 | 56,000 | 784,000 | 2,601,814 | 2.5 M to 2.6 M (+2.20 %) |
Feb 10 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Buy | C | 0.00 | 191,764 | 0 | 2,545,814 | 2.4 M to 2.5 M (+8.15 %) |
Feb 10 2017 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Buy | C | 0.00 | 2,354,050 | 0 | 2,354,050 | 0 to 2.4 M |
Oct 20 2016 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 |
Page: 1